http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102333660-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 |
filingDate | 2020-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102333660-B1 |
titleOfInvention | Novel Human Epidermal Growth Factor-Trigger Factor Fusion Protein and Uses Thereof |
abstract | The present invention relates to a novel human epidermal growth factor (hEGF)-Trigger factor (TF) fusion protein and uses thereof, and more particularly, to a human epidermal growth factor (hEGF)-TF (Trigger Factor) fusion of the present invention The protein is a signal peptide of xylanase derived from Bacillus subtilis; human epidermal growth factor (hEGF); And Escherichia coli-derived TF (Trigger Factor) is fused, not only to improve the water solubility and expression rate of the target protein, but also to significantly enhance useful effects such as skin cell growth increase and wound healing effect, so the effectiveness of functional cosmetic compositions and pharmaceutical compositions As an ingredient, it will be widely used in various industries. |
priorityDate | 2019-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 372.